Two-year efficacy and safety outcomes of the pivotal OASIS Study using the Revi(&#xae;) System for treatment of urgency urinary incontinence

Overactive BladderUrinary Incontinence

Gene Therapy With URO-902 (pVAX/hSlo) for the Treatment of Female Patients With Overactive Bladder and Urge Urinary Incontinence: Safety and Efficacy From a Randomized Phase 2a Trial

J Urol

Enemchukwu EA, Kalota S, Robertson K, Ge S, Lu J, Badger H, Mujais S, Peters KM

doi: 10.1097/JU.0000000000004373

Urinary Incontinence

Outcomes of the Victo™ adjustable artificial urinary sphincter in the treatment of male incontinence

BJU Int

Krhut J, Bartáková L, Kondé A, Sýkora RP, Rychlý T, Zachoval R

doi: 10.1111/bju.16511

Urinary Incontinence

Efficacy and Safety of TAS-303 in Female Patients With Stress Urinary Incontinence: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial

J Urol

Takahashi S, Kato K, Yokoyama O, Takei M, Gotoh M

doi: 10.1097/JU.0000000000004024

Further Publications Urology

Long-Term Outcomes of Recurrent Bulbar Urethral Stricture Treatment With the Optilume Drug-Coated Balloon: 5-year Results From the ROBUST I Study

J Urol

DeLong J, Virasoro R, Pichardo M, Estrella R, Rodríguez Lay R, Espino G, Elliott S

doi: 10.1097/JU.0000000000004229

Endometriosis

Efficacy and safety of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg combination in a cyclic regimen for the treatment of endometriosis-associated pain and objective gynecological findings: A multicenter, placebo-controlled, double-blind, randomized study

Fertil Steril

Harada T, Kobayashi T, Hirakawa A, Takayanagi T, Nogami M, Mochiyama T, Hirayama M, Foidart JM, Osuga Y

doi: 10.1016/j.fertnstert.2024.07.011

Reproductive Health

Efficacy and safety of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg combination in a cyclic regimen for the treatment of primary and secondary dysmenorrhea: A multicenter, placebo-controlled, double-blind, randomized study

Fertil Steril

Osuga Y, Kobayashi T, Hirakawa A, Takayanagi T, Nogami M, Tayzar K, Mochiyama T, Hirayama M, Foidart JM, Harada T

doi: 10.1016/j.fertnstert.2024.11.003

Further Publications Gynecology

Preterm Birth Frequency and Associated Outcomes From the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine

Obstet Gynecol

Madhi SA, Kampmann B, Simões EAF, Zachariah P, Pahud BA, Radley D, Sarwar UN, Shittu E, Llapur C, Pérez Marc G, Maldonado Y, Kachikis A, Zar HJ, Swanson KA, Lino MM, Anderson AS, Gurtman A, Munjal I

doi: 10.1097/AOG.0000000000005817

Urinary Incontinence

Artificial Urinary Sphincter Implants in Men: a National Healthcare Data System-based Study to Assess Reinterventions in France

J Urol

Lenfant L, Taillé Y, Chartier-Kastler E, Lukacs B, Seisen T, Roupret M, Beaugerie A, Vicaut E, Mozer PC

doi: 10.1097/JU.0000000000004285

Pregnancy and Childbirth

Outcome reporting in studies on pregnant women with cardiac disease: a systematic review: Outcomes in studies on pregnancy and heart disease

Am Heart J

Hall C, Shishkina A, Thurman R, Ashraf R, Pal A, Horn D, Keepanasseril A, D'Souza R

doi: 10.1016/j.ahj.2024.09.008

Gynecology · Urology

Two-year efficacy and safety outcomes of the pivotal OASIS Study using the Revi(®) System for treatment of urgency urinary incontinence

Related content

Gene Therapy With URO-902 (pVAX/hSlo) for the Treatment of Female Patients With Overactive Bladder and Urge Urinary Incontinence: Safety and Efficacy From a Randomized Phase 2a Trial

Outcomes of the Victo™ adjustable artificial urinary sphincter in the treatment of male incontinence

Efficacy and Safety of TAS-303 in Female Patients With Stress Urinary Incontinence: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial

Long-Term Outcomes of Recurrent Bulbar Urethral Stricture Treatment With the Optilume Drug-Coated Balloon: 5-year Results From the ROBUST I Study

Efficacy and safety of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg combination in a cyclic regimen for the treatment of endometriosis-associated pain and objective gynecological findings: A multicenter, placebo-controlled, double-blind, randomized study

Efficacy and safety of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg combination in a cyclic regimen for the treatment of primary and secondary dysmenorrhea: A multicenter, placebo-controlled, double-blind, randomized study

Preterm Birth Frequency and Associated Outcomes From the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine

Artificial Urinary Sphincter Implants in Men: a National Healthcare Data System-based Study to Assess Reinterventions in France

Outcome reporting in studies on pregnant women with cardiac disease: a systematic review: Outcomes in studies on pregnancy and heart disease